Patterns of serum type 1 and type 2 immune markers in healthy carriers of HTLV-I
- 20 April 2006
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 78 (6), 847-852
- https://doi.org/10.1002/jmv.20633
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Cytokine Profile and Immunomodulation in Asymptomatic Human T-Lymphotropic Virus Type 1–Infected Blood DonorsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26Clinical and Experimental Immunology, 2000
- Gender Difference in Skin Reactivity to Purified Protein Derivative Among Carriers of HTLV-I in JapanJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD)Clinical and Experimental Immunology, 1997
- Correlation between Human T Cell Lymphotropic Virus Type-1 and Strongyloides stercoralis Infections and Serum Immunoglobulin E Responses in Residents of Okinawa, JapanThe American Journal of Tropical Medicine and Hygiene, 1997
- Infectious Complications of Human T Cell Leukemia/Lymphoma Virus Type I InfectionClinical Infectious Diseases, 1996
- Expression, Structure, and Function of the CD23 AntigenAdvances in Immunology, 1991
- Suppression of tuberculin skin reaction in healthy HTLV‐I carriers from JapanInternational Journal of Cancer, 1988
- Epstein‐barr virus‐specific antibodies in patients with adult T‐cell leukemia (ATL) and healthy ATL virus‐carriersInternational Journal of Cancer, 1983
- Epstein-barr virus specific diagnostic tests in infectous mononucleosisHuman Pathology, 1974